BioCentury
ARTICLE | Company News

Sangamo, Bristol-Myers deal

April 10, 2000 7:00 AM UTC

Sangamo will provide BMY its Universal GeneTools, which use engineered zinc finger DNA recognition proteins to regulate gene expression, for use in BMY's internal research and validation programs. ...